Nexavar (sorafenib) — Medica
Ovarian, fallopian tube, or primary peritoneal cancer (platinum-resistant)
Initial criteria
- age ≥ 18 years
- platinum-resistant disease
- used in combination with topotecan
Approval duration
1 year
Ovarian, fallopian tube, or primary peritoneal cancer (platinum-resistant)
1 year